Mercom posts strong Q3 numbers in health IT sector

Communications and consulting firm Mercom Capital Group has released health IT funding and merger and acquisition activity for the third quarter, noting a “greater quarter” with $207 million in venture capital (VC) funding.

VC funding in the health IT sector in Q3 2011 more than tripled with $207 million with 17 deals compared with $66 million in six deals in the previous quarter, the Autsin, Texas-headquartered Mercom stated. “VC funding for the same quarter last year came to $62 million in seven deals. Fifty different investors participated in these funding rounds,” Mercom said in a statement.

Top VC funding rounds included a $75 million raise by ZocDoc, $27 million by Awarepoint , $20.1 million by CareCloud, $20 million by One Medical Group and $20 million by SeeChange Health.

According to the company, merger and acquisition activity in the health IT sector surged in Q3 2011 amounting to $4.7 billion in 37 transactions compared to $703 million in Q2 2011.

Major M&A transactions included the acquisition of Emdeon by Blackstone Capital Partners for $3 billion, Vantage by General Dynamics for $960 million, Sage Healthcare by Vista Equity Partners for $320 million, PayFlex by Aetna for $202 million and M*Modal by MedQuist Holdings for $130 million.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.